A. Kiselyov

Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies

S. Bunimovich-Mendrazitsky, A. Kiselyov, Vladimir Startsev, 2015, BBA clinical.

Robust Reductions of Body Weight and Food Intake by an Oxytocin Analog in Rats

C. Roth, R. Pittner, E. Lawson, 2021, Frontiers in Physiology.

Novel Long-Acting Oxytocin Analog with Increased Efficacy in Reducing Food Intake and Body Weight

C. Roth, E. Lawson, A. Kiselyov, 2022, International journal of molecular sciences.

iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling

R. Maehr, O. King, A. Bang, 2022, eLife.

Key signaling pathways in the muscle‐invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment

S. Bunimovich-Mendrazitsky, A. Kiselyov, Vladimir Startsev, 2016, International journal of cancer.

Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates

J. Wityak, H. Lashuel, C. Scheich, 2021, Scientific Reports.

Mathematical model for BCG-based treatment of type 1 diabetes

T. Lazebnik, S. Bunimovich-Mendrazitsky, A. Kiselyov, 2023, Physica A: Statistical Mechanics and its Applications.

Clinically Relevant Mathematical Model for the BCG-based Treatment Of Type 1 Diabetes

T. Lazebnik, S. Bunimovich-Mendrazitsky, A. Kiselyov, 2021, bioRxiv.